Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin P Robertson

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
Cancer Biology & Therapy|December 14, 2011
The Akt signaling pathway: an emerging therapeutic target in malignant melanomaSubbaRao V Madhunapantula, Paul J Mosca, Gavin P Robertson
Biochemical Pharmacology|May 11, 2010
Targeting the MAPK pathway in melanoma: why some approaches succeed and other failGajanan S Inamdar, SubbaRao V Madhunapantula, Gavin P Robertson
Pigment Cell & Melanoma Research|June 5, 2009
Use of liposomes as drug delivery vehicles for treatment of melanomaMelissa A Tran, Rebecca J Watts, Gavin P Robertson
Cancer Research|May 20, 2016
The Role of Cholesterol in CancerOmer F Kuzu, Mohammad A Noory, Gavin P Robertson
Pigment Cell & Melanoma Research|May 9, 2014
Growth inhibitory effects of large subunit ribosomal proteins in melanomaGregory R Kardos, Mu-Shui Dai, Gavin P Robertson
Cancer Research|May 3, 2008
Akt3 and mutant V600E B-Raf cooperate to promote early melanoma developmentMitchell Cheung, Arati Sharma, SubbaRao V Madhunapantula, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinomaThomas C Stover, Arati Sharma, Gavin P Robertson, et al.
Pigment Cell & Melanoma Research|September 17, 2013
Identification of glycogen synthase kinase 3α as a therapeutic target in melanomaSubbaRao V Madhunapantula, Arati Sharma, Raghavendra Gowda, et al.
Cancer Letters|February 7, 2017
Future of circulating tumor cells in the melanoma clinical and research laboratory settingsLuisa M De Souza, Bailey M Robertson, Gavin P Robertson
Journal of Nanomedicine & Nanotechnology|July 12, 2014
Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapyRaghavendra Gowda, Nathan R Jones, Shubhadeep Banerjee, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Cancer Biology & Therapy|December 14, 2011
The Akt signaling pathway: an emerging therapeutic target in malignant melanomaSubbaRao V Madhunapantula, Paul J Mosca, Gavin P Robertson
Biochemical Pharmacology|May 11, 2010
Targeting the MAPK pathway in melanoma: why some approaches succeed and other failGajanan S Inamdar, SubbaRao V Madhunapantula, Gavin P Robertson
Pigment Cell & Melanoma Research|June 5, 2009
Use of liposomes as drug delivery vehicles for treatment of melanomaMelissa A Tran, Rebecca J Watts, Gavin P Robertson
Cancer Research|May 20, 2016
The Role of Cholesterol in CancerOmer F Kuzu, Mohammad A Noory, Gavin P Robertson
Pigment Cell & Melanoma Research|May 9, 2014
Growth inhibitory effects of large subunit ribosomal proteins in melanomaGregory R Kardos, Mu-Shui Dai, Gavin P Robertson
Cancer Research|May 3, 2008
Akt3 and mutant V600E B-Raf cooperate to promote early melanoma developmentMitchell Cheung, Arati Sharma, SubbaRao V Madhunapantula, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinomaThomas C Stover, Arati Sharma, Gavin P Robertson, et al.
Pigment Cell & Melanoma Research|September 17, 2013
Identification of glycogen synthase kinase 3α as a therapeutic target in melanomaSubbaRao V Madhunapantula, Arati Sharma, Raghavendra Gowda, et al.
Cancer Letters|February 7, 2017
Future of circulating tumor cells in the melanoma clinical and research laboratory settingsLuisa M De Souza, Bailey M Robertson, Gavin P Robertson
Journal of Nanomedicine & Nanotechnology|July 12, 2014
Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapyRaghavendra Gowda, Nathan R Jones, Shubhadeep Banerjee, et al.
Pageof 12